A detailed history of Coldstream Capital Management Inc transactions in Dexcom Inc stock. As of the latest transaction made, Coldstream Capital Management Inc holds 11,253 shares of DXCM stock, worth $902,940. This represents 0.02% of its overall portfolio holdings.

Number of Shares
11,253
Previous 7,745 45.29%
Holding current value
$902,940
Previous $878,000 14.12%
% of portfolio
0.02%
Previous 0.02%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$64.0 - $116.06 $224,512 - $407,138
3,508 Added 45.29%
11,253 $754,000
Q2 2024

Aug 07, 2024

BUY
$110.31 - $140.45 $140,534 - $178,933
1,274 Added 19.69%
7,745 $878,000
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $38,377 - $47,073
336 Added 5.48%
6,471 $897,000
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $125,313 - $206,105
1,660 Added 37.09%
6,135 $761,000
Q3 2023

Nov 02, 2023

SELL
$86.06 - $137.93 $85,887 - $137,654
-998 Reduced 18.23%
4,475 $417,000
Q2 2023

Aug 03, 2023

BUY
$112.47 - $130.98 $449 - $523
4 Added 0.07%
5,473 $703,000
Q1 2023

May 15, 2023

SELL
$104.0 - $122.92 $1,768 - $2,089
-17 Reduced 0.31%
5,469 $635,000
Q4 2022

Jan 10, 2023

BUY
$84.98 - $122.67 $145,995 - $210,747
1,718 Added 45.59%
5,486 $0
Q2 2022

Aug 08, 2022

BUY
$67.99 - $132.89 $256,186 - $500,729
3,768 New
3,768 $281,000
Q2 2022

Aug 08, 2022

SELL
$67.99 - $132.89 $50,652 - $99,003
-745 Closed
0 $0
Q1 2022

May 11, 2022

SELL
$94.08 - $130.2 $17,310 - $23,956
-184 Reduced 19.81%
745 $381,000
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $120,649 - $151,259
929 New
929 $499,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Coldstream Capital Management Inc Portfolio

Follow Coldstream Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coldstream Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Coldstream Capital Management Inc with notifications on news.